Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up

Transplant Proc. 1997 Feb-Mar;29(1-2):1174-7. doi: 10.1016/s0041-1345(96)00535-0.
No abstract available

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Child
  • Cohort Studies
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Graft Rejection / epidemiology
  • Humans
  • Immunosuppression Therapy / adverse effects
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / therapeutic use
  • Liver Transplantation / immunology*
  • Liver Transplantation / physiology
  • Postoperative Complications / epidemiology*
  • Time Factors

Substances

  • Immunosuppressive Agents